Persistent Pathogens Linking Socioeconomic Position and Cardiovascular Disease - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Persistent Pathogens Linking Socioeconomic Position and Cardiovascular Disease

Description:

2005, 30,147 heart disease and stroke deaths in Michigan4 ... systemic inflammatory response, and risk of stable coronary artery disease: role ... – PowerPoint PPT presentation

Number of Views:76
Avg rating:3.0/5.0
Slides: 33
Provided by: asim7
Category:

less

Transcript and Presenter's Notes

Title: Persistent Pathogens Linking Socioeconomic Position and Cardiovascular Disease


1
Persistent Pathogens Linking Socioeconomic
Position and Cardiovascular Disease
  • Amanda M. Simanek, MPH
  • PhD pre-candidate
  • University of Michigan-School of Public Health
  • Department of Epidemiology
  • Michigan Epidemiology Conference
  • April 4th, 2008

PhD Advisor Dr. Allison Aiello
2
Outline
  • Background
  • Hypothesis
  • Methods
  • Results
  • Discussion

3
Background
  • Deaths from heart disease1
  • Decreased by over 50 in the past 60 years
  • Cardiovascular disease (CVD) is leading cause of
    death in U.S. and Michigan2
  • Women and men
  • 2004, 27 of all deaths nationally3
  • 2005, 30,147 heart disease and stroke deaths in
    Michigan4
  • Socioeconomic disparities in CVD persist 5-9
  • Reported heart disease, ischemic heart disease,
    hypertension, and stroke inversely related to
    poverty status, education and income10

4
Background
  • Risk Factors
  • smoking
  • physical inactivity
  • higher body mass index (BMI)
  • higher low-density lipoproteins levels
  • However, studies have shown that not all of the
    variation in CVD, according to socioeconomic
    position (SEP) is explained by these traditional
    risk factors11,12

5
Background
  • Alternative mechanisms?
  • Biological Influences of Psychosocial Stress
  • Inflammatory markers such as C-reactive protein
    and Interleukin-6 13-17
  • - Reactivation of persistent infections
  • Act as pro-inflammatory stimuli and contribute to
    chronic inflammation 18-21

6
Biological Pathways Between Infection and CVD
Chronic Infection/ Reactivation
Inflammatory Response
Endothelial Damage
Lipid/Debris Accumulation
Monocytes/ Macrophages/ Foam Cells
Intimal Thickening
Atherosclerosis
Fatty Streak
7
Background
  • Studies have shown
  • Association between SEP and infections22-26
  • Cytomegalovirus (CMV),
  • Herpes simplex 1 and 2 (HSV-1 and 2)
  • Chlamydia pneumoniae
  • Helicobacter pylori
  • Others
  • Associations between pathogens and CVD
    outcomes27-40
  • Individual pathogens
  • Various combinations of pathogens

8
Hypothesis
Socioeconomic Position
Cardiovascular Disease
Pathogens
Pathogens
b
a
ab indirect effect
Cardiovascular Disease
Socioeconomic Position
c direct effect
ab c total effect
Pathogens of Interest CMV, HSV-1, Both
9
Hypothesis
  • CMV
  • HSV-1
  • Infections initially contracted at a young age
  • High seroprevalence by age 50
  • Persist in latent state with periodic
    reactivation over the life course
  • Opportunity to cause chronic inflammation

10
Methods
11
Methods
  • Study Population and Study Design
  • National Health and Nutrition Examination Survey
    (NHANES) III (1988-1994)
  • Cross-sectional study
  • Age 45
  • History of CVD
  • Seropositivity CMV (N7866),  HSV-1 (N4156),
    and both pathogens (N4136)

12
Methods
  • Measures
  • Exposure
  • SEP years of education
  • Mediator
  • Pathogens CMV and HSV-1 IgG antibody
    seroprevalence
  • Pathogen burden total number of pathogens to
    which subjects were seropositive (range 0-2)
  • Outcome
  • CVD History reported history of one or more
    conditions
  • congestive heart failure, stroke or heart attack
  • Covariates
  • Age, gender, race, smoking and diabetes

13
Methods
  • Statistical Analyses
  • SAS with SUDAAN (SAS Institute, Inc., Cary, NC).
  • Weights and adjustments for strata and clustering
  • Logistic regression
  • Odds ratios and 95 percent confidence intervals
    (95 CI)
  • Mediation
  • Sobel Test Statistic
  • compares the strength of the indirect effect of
    SEP on CVD (mediated by pathogen) to the null
    hypothesis that the indirect effect equals zero

14
Confounders
Age Gender Race Smoking Diabetes
Age Gender Race
Age Gender Race
Mediators
Pathogens
Cardiovascular Disease
Socioeconomic Position
Outcome
Exposure
15
Results
16
Relationship Between Covariates and History of
Cardiovascular Disease
17
Relationship Between Covariates and History of
Cardiovascular Disease
18
Seropositivity
19
  • Mediation

20
Testing Mediation
CVD
SEP
Model 1 unadjusted (N8134) Model 2 adjusted
for age, gender and race (N8134) Significant at
plt0.05  
21
Testing Mediation
SEP Pathogens
Model with CMV adjusted for age, gender and race
(N7810) Models with HSV-1 (N4129) or both
pathogens (N4109) adjusted for age and race
Significant at plt0.05
22
Testing Mediation
Pathogens CVD, Controlling for
SEP
 
Model with CMV adjusted for age, gender,
diabetes and education (N7810) Model with HSV-1
adjusted for age, gender and education
(N4129) Model with both pathogens adjusted for
age, race, diabetes and education
(N4073) Significant at Plt0.05
23
Testing Mediation  
SEP CMV CVD
Model 1 adjusted for age and gender,
N7810. Model 2 adjusted for age, gender and CMV
seropositivity, N7810. Significant at plt0.05
24
Discussion
  • After controlling for CMV, the odds of CVD
    history for those at the lowest education level
    compared to the highest were reduced by 7.5
  • CMV was the only pathogen to partially mediate
    the relationship between SEP and CVD
  • Seropositivity to HSV-1 and to both pathogens was
    not associated with CVD history in this sample
  • Reactivation with CMV over the life course may
    have more detrimental effects on CVD than HSV-1
  • CMV more consistently linked with CVD than
    HSV-142-45
  • More likely to be found in the vasculature

25
Limitations
  • Cross-sectional
  • However, exposure to these herpes viruses
    generally occurs early in life
  • Self-reported CVD history
  • Measurement error

26
Conclusion
  • Next step
  • Examine how these infections mediate relationship
    between SEP and CVD incidence over time
  • NHANES mortality data
  • Implications
  • Uncover social and biological mechanisms
    underlying SEP disparities in CVD
  • Prevention of and/or vaccination against CMV
    infection could serve to ameliorate SEP
    disparities in CVD

27
Acknowledgements
  • Allison E. Aiello, PhD
  • Jennifer Beam Dowd, PhD
  • Questions?

28
References
  • National Center for Health Statistics Health,
    United States, 2007 With Chartbook on Trends in
    the Health of Americans Hyattsville, MD 2007
  • Heron,MP. DeathsLeading causes for 2004.
    National vital statistics reports vol 56 no 5.
    Hyattsville,MD National Center for Health Data
    and Methods Statistics. 2007.
  • Michigan Health Statistics. Division for Vital
    Records and Health Statistics Michigan
    Department of Community Health. January 2007.
  • Behavioral Risk Factor Survey, Michigan
    Department of Community Health (MDCH), 2005.
  • Kaplan GA, Keil JE. Socioeconomic factors and
    cardiovascular disease A review of the
    literature. Circulation. 1993881973-1998.
  • Galobardes B, Smith GD, Lynch JW. Systematic
    review of the influence of childhood
    socioeconomic circumstances on risk for
    cardiovascular disease in adulthood. Ann
    Epidemiol. 20061691-104.
  • Ljung R, Hallqvist J. Socioeconomic position,
    clustering of risk factors, and the risk of
    myocardial infarction. Am J Public Health.
    2007971927-8 author reply 1928-9.
  • Hayes DK, Greenlund KJ, Denny CH, Keenan NL,
    Croft JB. Disparities in multiple risk factors
    for heart disease and stroke, 2003. MMWR.
    200554 113116.
  • Steptoe, A. and Marmot, M. Socioeconomic Status
    and Coronary Heart Disease A Psychobiological
    Perspective. Population and Development Review,
    Vol. 30, Supplement Aging, Health, and Public
    Policy (2004), pp. 133-150
  • Mensah G, Mokdad A, Ford E, Greenlund K, Croft J.
    State of disparities in cardiovascular health in
    the united states. Circulation.
    20051111233-1241.
  • Kivimaki M, Lawlor DA, Davey Smith G, et al.
    Socioeconomic position, co-occurrence of
    behavior-related risk factors, and coronary heart
    disease The finnish public sector study. Am J
    Public Health. 200797874-879.
  • Lawlor DA, Ebrahim S, Davey Smith G. Adverse
    socioeconomic position across the lifecourse
    increases coronary heart disease risk
    cumulatively Findings from the british women's
    heart and health study. J Epidemiol Community
    Health. 200559785-793.

29
References
  • Ranjit N, Diez-Roux AV, Shea S, Cushman M, Ni H,
    Seeman T. Socioeconomic position, race/ethnicity,
    and inflammation in the multi-ethnic study of
    atherosclerosis. Circulation. 20071162383-2390.
  • Nazmi A, Victora CG. Socioeconomic and
    racial/ethnic differentials of C-reactive protein
    levels A systematic review of population-based
    studies. BMC Public Health. 20077212.
  • Zakai NA, Katz R, Jenny NS, et al. Inflammation
    and hemostasis biomarkers and cardiovascular risk
    in the elderly The cardiovascular health study.
    J Thromb Haemost. 200751128-1135
  • Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD,
    Fowkes FG. Relative value of inflammatory,
    hemostatic, and rheological factors for incident
    myocardial infarction and stroke The edinburgh
    artery study. Circulation. 20071152119-2127.
  • Mendall MA, Patel P, Ballam L, Strachan D,
    Northfield TC. C reactive protein and its
    relation to cardiovascular risk factors a
    population based cross sectional study.BMJ. 1996
    Apr 27312(7038)1061-5.
  • Goyal P, Kale SC, Chaudhry R, Chauhan S, Shah N.
    Association of common chronic infections with
    coronary artery disease in patients without any
    conventional risk factors. Indian Journal of
    Medical Research. 2007125129-136 Accessed 14
    August 2007
  • Schmaltz HN, Fried LP, Xue QL, Walston J, Leng
    SX, Semba RD. Chronic cytomegalovirus infection
    and inflammation are associated with prevalent
    frailty in community-dwelling older women. J Am
    Geriatr Soc. 200553747-54.
  • Soderberg-Naucler C. Does cytomegalovirus play a
    causative role in the development of various
    inflammatory diseases and cancer? J Intern Med.
    2006259219-46.
  • Aiello AE, Haan M, Blythe L, Moore K, Gonzalez
    JM, Jagust W. The influence of latent viral
    infection on rate of cognitive decline over 4
    years. J Am Geriatr Soc. 2006541046-54.
  • Schillinger JA, Xu F, Sternberg MR, et al.
    National seroprevalence and trends in herpes
    simplex virus type 1 in the united states,
    1976-1994. Sex Transm Dis. 200431753-60.

30
References
  • Staras SA, Dollard SC, Radford KW, Flanders WD,
    Pass RF, Cannon MJ. Seroprevalence of
    cytomegalovirus infection in the united states,
    1988-1994. Clin Infect Dis. 2006431143-51.
  • Dowd JB, Haan MN, Blythe L, Moore K, Aiello AE.
    Socioeconomic Gradients in Immune Response to
    Latent Infection. Am J Epidemiol. 2007 Sep 1
  • Cohen S, Doyle WJ, Turner RB, Alper CM, Skoner
    DP. Childhood socioeconomic status and host
    resistance to infectious illness in adulthood.
    Psychosom Med. 2004 Jul-Aug66(4)553-8.
  • Malaty HM, Graham DY. Importance of childhood
    socioeconomic status on the current prevalence of
    Helicobacter pylori infection. Gut. 1994
    Jun35(6)742-5.
  • Ayada K, Yokota K, Kobayashi K, Shoenfeld Y,
    Matsuura E, Oguma K. Chronic infections and
    atherosclerosis. Ann N Y Acad Sci. 2007
    Jun1108594-602.
  • Paquette DW, Brodala N, Nichols TC.
    Cardiovascular disease, inflammation, and
    periodontal infection. Periodontol 2000.
    200744113-26.
  • Ford PJ, Yamazaki K, Seymour GJ. Cardiovascular
    and oral disease interactions what is the
    evidence? Prim Dent Care. 2007 Apr14(2)59-66.
  • Zebrack JS, Anderson JL. The role of infection in
    the pathogenesis of cardiovascular disease. Prog
    Cardiovasc Nurs. 2003 Winter18(1)42-9.
  • Zebrack JS, Anderson JL.The role of inflammation
    and infection in the pathogenesis and evolution
    of coronary artery disease. Curr Cardiol Rep.
    2002 Jul4(4)278-88.
  • Armitage GC. Periodontal infections and
    cardiovascular disease--how strong is the
    association? Oral Dis. 2000 Nov6(6)335-50.
  • Epstein SE, Zhu J, Burnett MS, Zhou YF,
    Vercellotti G, Hajjar D. Infection and
    atherosclerosis potential roles of pathogen
    burden and molecular mimicry. Arterioscler Thromb
    Vasc Biol. 2000 Jun20(6)1417-20.
  • Beck JD, Offenbacher S, Williams R, Gibbs P,
    Garcia R. Periodontitis a risk factor for
    coronary heart disease? Ann Periodontol. 1998
    Jul3(1)127-41.

31
References
  • Goyal P, Kalek SC, Chaudhry R, Chauhan S, Shah N.
    Association of common chronic infections with
    coronary artery disease in patientswithout any
    conventional risk factors. Indian J Med Res. 2007
    Feb125(2)129-36.
  • Rothenbacher D, Brenner H, Hoffmeister A, Mertens
    T, Persson K, Koenig W. Relationship between
    infectious burden, systemic inflammatory
    response, and risk of stable coronary artery
    disease role of confounding and reference group.
    Atherosclerosis. 2003 Oct170(2)339-45.
  • Georges JL, Rupprecht HJ, Blankenberg S, Poirier
    O, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien
    F, Tiret L AtheroGene Group. Impact of pathogen
    burden in patients with coronary artery disease
    in relation to systemic inflammation and
    variation in genes encoding cytokines. Am J
    Cardiol. 2003 Sep 192(5)515-21.1
  • Auer J, Leitinger M, Berent R, Prammer W, Weber
    T, Lassnig E, Eber B. Influenza A and B IgG
    seropositivity and coronary atherosclerosis
    assessed by angiography. Heart Dis. 2002
    Nov-Dec4(6)349-54.
  • Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein
    SE, Quyyumi AA. Predisposition to atherosclerosis
    by infections role of endothelial dysfunction.
    Circulation. 2002 Jul 9106(2)184-90.
  • Zhu J, Nieto FJ, Horne BD, Anderson JL,
    Muhlestein JB, Epstein SE. Prospective study of
    pathogen burden and risk of myocardial infarction
    or death. Circulation. 2001 Jan
    2103(1)45-51.21. Zhu J, Quyyumi AA, Norman JE,
    Csako G, Waclawiw MA, Shearer GM, Epstein SE.
    Effects of total pathogen burden on coronary
    artery disease risk and C-reactive protein
    levels. Am J Cardiol. 2000 Jan 1585(2)140-6.
  • Baron, R. and Kenny, D. The moderator-mediator
    variable distinction in social psychological
    research Conceptual, strategic, and statistical
    considerations. Journal of Personality and Social
    Psychology. 1968511173-1182.
  • MacKinnon DP, Dwyer JH. Estimating mediated
    effects in prevention studies. Evaluation Review.
    199317144-158.
  • Chiu B, Viira E, Tucker W, Fong IW. Chlamydia
    pneumoniae, cytomegalovirus, and herpes simplex
    virus in atherosclerosis of the carotid artery.
    Circulation. 1997 Oct 796(7)2144-8
  • Espinola-Klein C, Rupprecht HJ, Blankenberg S,
    Bickel C, Kopp H, Rippin G, Hafner G, Pfeifer U,
    Meyer J. Are morphological or functional changes
    in the carotid artery wall associated with
    Chlamydia pneumoniae, Helicobacter pylori,
    cytomegalovirus, or herpes simplex virus
    infection? Stroke. 2000 Sep31(9)2127-33
  • Muhlestein JB, Anderson JL. Chronic infection and
    coronary artery disease. Cardiol Clin. 2003
    Aug21(3)333-62.

32
Methods
  • Sobel Test Statistic
  • -compares the strength of the indirect effect of
    SEP on CVD (mediated by pathogen) to the null
    hypothesis that it equals zero
  • ab
  • Standard error of ab
  • -yields a critical ratio (z-score)
  • -usually compared with the critical value from
    the standard normal distribution
  • -assumes large sample size
Write a Comment
User Comments (0)
About PowerShow.com